Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenomatous Polyposis Coli (Phase 2)
Adrenal Gland Neoplasms (Phase 1)
Alveolitis, Extrinsic Allergic (Early Phase 1)
Bile Duct Neoplasms (Phase 1)
Brain Neoplasms (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Cholangiocarcinoma (Phase 1)
Idiopathic Interstitial Pneumonias (Early Phase 1)
Lung Diseases, Interstitial (Early Phase 1)
Lymphoma (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pneumoconiosis (Early Phase 1)
Pneumonia (Early Phase 1)
Prostatic Neoplasms (Phase 1)
Pulmonary Fibrosis (Early Phase 1)
Radiation Pneumonitis (Early Phase 1)
Sarcoma (Early Phase 1)
Stomach Neoplasms (Phase 2)
Testicular Neoplasms (Phase 1)
Thymoma (Phase 1)
Thyroid Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue